TUNG-HUNG SUPeng, Cheng-YuanCheng-YuanPengChang, Shan-HanShan-HanChangTAI-CHUNG TSENGCHUN-JEN LIUCHI-LING CHENCHEN-HUA LIUHUNG-CHIH YANGPEI-JER CHENJIA-HORNG KAO2022-09-292022-09-292022-030929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/623263The risk of hepatocellular carcinoma (HCC) is reduced but not eliminated after nucleos(t)ide analogue (NA) therapy in chronic hepatitis B (CHB). We aimed to investigate the role of serum Prothrombin Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) and alpha-fetoprotein in predicting HCC and mortality in cirrhotic CHB patients at virological remission (VR) following NA therapy.enAFP; DCP; Des-carboxyprothrombin; Liver cancer; Prothrombin induced by vitamin K Absence or antagonist-IIjournal article10.1016/j.jfma.2021.08.003344527852-s2.0-85113564092WOS:000784231500016